Oct 26 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- AROVELLA TO CLOSE ITS PERTH OROMIST RESEARCH AND DEVELOPMENT FACILITY AND FOCUS ON ITS INKT CELL THERAPY PLATFORM
- SEES CLOSURE OF FACILITY TO HAVE ESTIMATED COST SAVING OF A$1.5M PER ANNUM BASED ON HISTORICAL COSTS
(([email protected];))
News: ALA Arovella Therapeutics To Close Its Perth Oromist Research And Development Facility
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.7M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.0¢ | $78.33K | 678.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 565311 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 1333348 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.8¢ | 12.0¢ | 11.5¢ | 189773 | ||
| Last updated 15.12pm 21/05/2024 ? | |||||
| ALA (ASX) Chart |